Microenvironment immunomodulation

Microenvironment immunomodulation refers to interventions or biological processes that alter the immune landscape within specific tissue environments, primarily the tumor microenvironment. This can involve enhancing anti-tumor immune responses by overcoming immune suppression, targeting immunosuppressive cell populations (such as regulatory T cells, tumor-associated macrophages, myeloid-derived suppressor cells), modulating cytokine networks, or remodeling the extracellular matrix and vasculature to facilitate immune cell infiltration and function. Unlike a well-defined therapeutic target such as a receptor or enzyme, "microenvironment immunomodulation" describes a therapeutic goal or strategy involving a wide range of molecular and cellular targets, not a single specific molecule or protein[6][4][7][3][8][2][1].

Other names

Tumor microenvironment immunomodulationTME immunomodulationimmune modulation in the microenvironment

Modulation of immune cell activity (e.g., T cell activation, Treg suppression) within the tissue or tumor microenvironment[6][4][7] Alteration of cytokine and chemokine networks Remodeling of extracellular matrix and stromal cell interactions Targeting supportive cells (e.g., cancer-associated fibroblasts, myeloid-derived suppressor cells) to enhance anti-tumor immunity[4][3][6]